Secretary of State for Health and Social Care Wes Streeting has announced plans to offer weight loss jabs to unemployed individuals with obesity. This comes after he stated that the NHS spends £11b annually on obesity-related illnesses.
With a five-year trial ready to examine the effectiveness of weight loss drugs on employability, the government hopes to decrease unemployment. However, with questions arising as to whether this will constitute healthy weight loss, the diet injections have come under scrutiny.
Read on as we explore the new weight loss meds in full. We will uncover whether they could contribute to healthy weight loss, where the obesity treatment will be tested, and why there has been pushback.
But before you proceed, make sure to sign up for our newsletter. Here at the Employment Law Review, we publish regular updates from the sector. Subscribing is the only way to stay informed, so hit the button at the top to get started!
Weight Loss Jabs Considered in New Obesity Treatment
Following a new government initiative, weight loss jabs could be given to unemployed individuals with obesity. The medication used in the study will be Tirzepatide, produced by US pharmaceutical giant Eli Lilly and sold under Mounjaro.
READ: Power Dynamics at Work: Judge’s Love Letter to Junior Colleague Made Her Feel Devalued
This weight loss drug, initially developed to treat Type 2 diabetes, has demonstrated remarkable efficacy in aiding weight loss. The obesity treatment works by mimicking a hormone that influences insulin production and appetite control. Consequently, gastric emptying slows down, and individuals feel fuller, helping to reduce their calorie consumption. According to clinical research, these weight-loss meds are more effective than diet and exercise alone.
Like what you're reading? Don't forget to subscribe to our bi-weekly newsletter!
The Five-Year Trial Investigating Diet Injections
The five-year trial, taking place in Greater Manchester, will examine the health and employability outcomes of the weight loss jabs. It will analyse whether healthy weight loss is achievable and how the obesity treatment affects employability and sickness absences.
According to the government, the Health Innovation Manchester run trial will be essential. These diet injections could prevent conditions like diabetes and may address societal challenges such as unemployment. Considering that the last NHS survey revealed that almost a third of adults in England are obese, these weight loss jabs could prove vital.
Are Weight Loss Injections Worth It?
There has been a fair amount of scrutiny by the public and professionals concerning the weight loss jabs. While the diet injections may provide a short-term obesity treatment, experts have said they won’t offer a long-term healthy weight loss solution.
Obesity policy consultant Dr Dolly van Tulleken stated that the initiative was unachievable since millions would require treatment despite the sector only being able to accommodate thousands annually. She added that this policy was simply a recycled idea that had previously failed.
Elsewhere, the Joint Council for Cosmetic Practitioners (JCCP) warned against the potential side effects of such weight loss drugs. They explained that while the diet injections may assist with losing weight, their use could lead to:
- Nausea
- Diarrhoea
- Vomiting
- Constipation
Furthermore, the JCCP warns that the “injectable nature” of the treatment could lead to potential addiction or misuse among users. And even if these issues don’t arise, the high cost of the medication makes long-term use unsustainable. Consequently, this could undermine the weight loss meds’ effectiveness, as research indicates that “weight often returns once treatment is discontinued”.
Healthcare professionals weren’t the only ones to criticise the weight loss jabs, though. Members of the public also provided their take. Much of the public criticism centred around the perception that the government should focus more on promoting lifestyle changes such as diet and exercise rather than pharmaceutical solutions.
Some feel that profit-driven motives are behind this push, as these treatments offer financial benefits that diet and exercise don’t. One critic said, “Why don’t they promote diet and exercise? No profit in that”. This reflects a broader societal tension between medical intervention and personal responsibility regarding health and weight management.
Are Weight Loss Jabs Safe?
Wegovy medication is already being used to help lose weight. What’s more, while Ozempic is a medication specifically used for type 2 diabetes, taking it for weight loss is gaining traction. Since such drugs are already in circulation, one might suggest that weight loss jabs are safe.
However, in addition to the common side effects already discussed, experts have warned about some severe complications. The clinical Lead at Zava, Dr Babak Ashrafi, explained that taking weight loss drugs like Wegovy medication could, in serious circumstances, lead to acute pancreatitis or anaphylaxis. Furthermore, although potentially effective, he stated that taking Ozempic for weight loss isn’t currently approved in the UK.
READ: Effective Strategies For Workplace Collaboration: Lessons From England vs Greece
Unfortunately, the side effects aren’t the only concern individuals have either. In addition, ethical considerations have been raised, with people questioning the pressure and stigma the treatments could bring.
It’s been suggested that the unemployed may feel forced to take the treatment, fearing not doing so could become a barrier to employment, undermining informed consent. Additionally, taking part in the initiative may lead to individuals believing their weight and inability to secure employment is under scrutiny, impacting their self-esteem and mental health. Therefore, while weight loss jabs can work and be effective, users must be aware of the potential physical and mental side effects that could compromise their health.
Tackling Obesity: Can Weight Loss Jabs Be the Solution?
Whether or not people support the government’s weight loss jab initiative, the statistics indicate that action is needed to tackle the nation’s obesity crisis. Addressing this issue would not only ease the strain on the NHS but also help individuals whose weight has become a barrier to employment. As the five-year trial evaluates the health and employability outcomes of this treatment, the government must address both health risks and ethical concerns to ensure healthy weight loss and the initiative’s long-term success.
We hope you found this employment insight helpful! Be sure to subscribe to our newsletter for more updates. Simply hit the button at the top and fill out the form to stay informed!